Suma Gopinathan

CIK: 0002071581

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)3 (50.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LXRX

LEXICON PHARMACEUTICALS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

LXRX
LEXICON PHARMACEUTICALS, INC.
Feb 28, 2026
Exercise(M)
Direct
14K shares-
LXRX
LEXICON PHARMACEUTICALS, INC.
Feb 28, 2026
Exercise(M)
Direct
20.3K shares-
LXRX
LEXICON PHARMACEUTICALS, INC.
Feb 28, 2026
Exercise(M)
Direct
65.6K shares-
LXRX
LEXICON PHARMACEUTICALS, INC.
Feb 28, 2026
Tax Payment(F)
Direct
24.3K shares at avg. $1.47$36K
LXRX
LEXICON PHARMACEUTICALS, INC.
Feb 12, 2026
Award(A)
Restricted Stock Units
Direct
238.5K shares-
LXRX
LEXICON PHARMACEUTICALS, INC.
Feb 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
357.7K shares-

		Type	Shares	Price		Ownership
Feb 28, 2026	LXRX LEXICON PHARMACEUTICALS, INC.	Exercise(M)	14,000	-	$0	Direct
Feb 28, 2026	LXRX LEXICON PHARMACEUTICALS, INC.	Exercise(M)	20,310	-	$0	Direct
Feb 28, 2026	LXRX LEXICON PHARMACEUTICALS, INC.	Exercise(M)	65,640	-	$0	Direct
Feb 28, 2026	LXRX LEXICON PHARMACEUTICALS, INC.	Tax Payment(F)	24,338	$1.47	$35,777	Direct
Feb 12, 2026	LXRX LEXICON PHARMACEUTICALS, INC.	Award(A) Restricted Stock Units	238,450	-	-	Direct
Feb 12, 2026	LXRX LEXICON PHARMACEUTICALS, INC.	Award(A) Stock Option (Right to Buy)	357,680	-	-	Direct

1-6 of 6 transactions

About Gopinathan Suma

Gopinathan Suma (SEC CIK 0002071581) files insider reports with the SEC as SVP, Discovery of LEXICON PHARMACEUTICALS, INC. (LXRX).

Signal8 holds 3 ownership filings by Gopinathan Suma (1 Form 3, 2 Form 4), filed between Jun 9, 2025 and Mar 3, 2026. Those filings report 6 transactions, from Feb 12, 2026 to Feb 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gopinathan Suma's filings is in THE WOODLANDS, TX.

Recent filings by Gopinathan Suma

Feb 28, 2026: Option exercises of LXRX shares (3 lines, Form 4, code M).
Feb 28, 2026: Tax withholding of LXRX shares (Form 4, code F).
Feb 12, 2026: Grants or awards of LXRX derivative securities (2 lines, Form 4, code A).

Other insiders filing for LEXICON PHARMACEUTICALS, INC. (LXRX)

Swain Judith L, Director
Sullivan Diane E., Director
SOBECKI CHRISTOPHER J, Director
Cheung Ivan, Director
BARKER SAM L, Director
Amouyal Philippe, Director

How to read Form 4 transaction codes